Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stokoe

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcomaMichael D Prados, Susan M Chang, Nicholas Butowski, et al.
Neuro-Oncology|February 23, 2011
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expressionShichun Zheng, E Andres Houseman, Zachary Morrison, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2017
Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistanceTerry D Crawford, Steffan Vartanian, Alexandre Côté, et al.
Cancer Research|September 18, 2025
Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung CancerMelat T Gebru, Timothy E Hoffman, Aaron Boudreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2012
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancersChaitali Parikh, Vasantharajan Janakiraman, Wen-I Wu, et al.
The New England Journal of Medicine|November 12, 2005
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitorsIngo K Mellinghoff, Maria Y Wang, Igor Vivanco, et al.
Communications Chemistry|August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Nature Biotechnology|December 9, 2014
A comprehensive transcriptional portrait of human cancer cell linesChristiaan Klijn, Steffen Durinck, Eric W Stawiski, et al.
Nature|July 30, 2010
Diverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S Jaiswal, Jeremy Stinson, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcomaMichael D Prados, Susan M Chang, Nicholas Butowski, et al.
Neuro-Oncology|February 23, 2011
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expressionShichun Zheng, E Andres Houseman, Zachary Morrison, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2017
Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistanceTerry D Crawford, Steffan Vartanian, Alexandre Côté, et al.
Cancer Research|September 18, 2025
Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung CancerMelat T Gebru, Timothy E Hoffman, Aaron Boudreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2012
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancersChaitali Parikh, Vasantharajan Janakiraman, Wen-I Wu, et al.
The New England Journal of Medicine|November 12, 2005
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitorsIngo K Mellinghoff, Maria Y Wang, Igor Vivanco, et al.
Communications Chemistry|August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Nature Biotechnology|December 9, 2014
A comprehensive transcriptional portrait of human cancer cell linesChristiaan Klijn, Steffen Durinck, Eric W Stawiski, et al.
Nature|July 30, 2010
Diverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S Jaiswal, Jeremy Stinson, et al.
Pageof 9